Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue, net $ 6,541,000 $ 2,404,000
Cost of revenue 4,677,000 1,977,000
Gross profit 1,864,000 427,000
Operating Expenses:    
Research and development 5,236,000 4,572,000
Sales and marketing 4,123,000 2,974,000
General and administrative 4,016,000 4,168,000
Total operating expenses 13,375,000 11,714,000
Loss from operations (11,511,000) (11,287,000)
Interest expense, net (9,000) (1,397,000)
Change in fair value of warrant liability 0 16,000
Gain on forgiveness of Paycheck Protection Program loan 859,000 0
Other expense, net (11,000) (34,000)
Warrant inducement expense (1,146,000) 0
Loss before provision for income taxes (11,818,000) (12,702,000)
Provision for income taxes 2,000 3,000
Net loss (11,820,000) (12,705,000)
Convertible preferred stock dividend (34,000) (80,000)
Deemed dividend on exchange of convertible preferred stock for common stock (1,192,000) 0
Deemed dividend from warrant repricing   (134,000)
Net loss attributable to common stockholders $ (13,046,000) $ (12,919,000)
Net loss per common share - Basic $ (1.05) $ (2.47)
Net loss per common share - Diluted $ (1.05) $ (2.47)
Weighted average number of common shares used in computing net loss per common share - Basic 12,401,642 5,235,263
Weighted average number of common shares used in computing net loss per common share - Diluted 12,401,642 5,235,263